Discontinuation report THALLIUM

Last updated on 2022-05-27 History
Report ID 161424
Drug Identification Number 02327945
Brand name THALLIUM
Common or Proper name thallous chloride Tl 201
Company Name LANTHEUS MI CANADA INC
Market Status MARKETED
Active Ingredient(s) THALLIUM CHLORIDE
Strength(s) 2MCI
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 mL vial
ATC code V09GX
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-12-31
Actual discontinuation date
Remaining supply date 2022-12-31
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply Barring unforeseen issues, supply will be available until the discontinuation date
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600
MONTREAL, QUEBEC
CANADA H4M 2X6
Company contact information lmicanada@lantheus.com 1-800-811-5500

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-05-27 French Compare
v2 2022-05-27 English Compare
v1 2022-05-27 English Compare

Showing 1 to 3 of 3